These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 9263354

  • 21. Is ticlopidine a safe alternative to aspirin for management of myeloproliferative disorders?
    Ruggeri M, Castaman G, Rodeghiero F.
    Haematologica; 1993; 78(6 Suppl 2):18-21. PubMed ID: 8039753
    [Abstract] [Full Text] [Related]

  • 22. European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.
    Landolfi R, Marchioli R.
    Semin Thromb Hemost; 1997; 23(5):473-8. PubMed ID: 9387206
    [Abstract] [Full Text] [Related]

  • 23. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation.
    van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, Michiels JJ.
    Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anagrelide: what was new in 2004 and 2005?
    Petrides PE.
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):399-408. PubMed ID: 16810615
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia.
    Treliński J, Tybura M, Smolewski P, Robak T, Chojnowski K.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):646-51. PubMed ID: 19741509
    [Abstract] [Full Text] [Related]

  • 36. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K.
    Semin Thromb Hemost; 1997 Dec; 23(4):349-56. PubMed ID: 9263351
    [Abstract] [Full Text] [Related]

  • 37. Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
    Michiels JJ.
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):30-6. PubMed ID: 10725980
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B.
    Circulation; 2004 Nov 02; 110(18):2946-51. PubMed ID: 15505105
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.